News & Updates

Men receiving testosterone therapy (TT) who develop polycythemia are at greater risk for major adverse cardiovascular events (MACE) and venous thromboembolism (VTE) in the first year of therapy, according to a recent study.

Individuals with nonalcoholic fatty liver disease (NAFLD) – despite having a lean body or healthy BMI – are at an elevated risk for peripheral vascular disease, stroke, and cardiovascular disease (CVD), a finding that surprises gastroenterologists and researchers at DDW 2022.

Increasing bodyweight may aggravate cardiovascular risk in patients with type 2 diabetes (T2D), a recent Japan study has found.

In patients with heart failure and recovered ejection fraction (HFrecEF), having a high ratio between the peak velocity of the early wave to early diastole (E/e’) may signal worse clinical prognosis, a recent study has found.